Neuroimaging in dystonia

Handbook of Dystonia

Volumn , Issue , 2006, Pages 93-106

  Troiano, A R ^a   Stoessl, A J ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 41249089131     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (95)

1. Oba H, Yagishita A, Terada H, et al. New and reliable MRI diagnosis for progressive supranuclear palsy. Neurology 2005; 64: 2050-2055.
2. Davie CA, Wenning GK, Barker GJ, et al. Differentiation of multiple system atrophy from idiopathic Parkinson’s disease using proton magnetic resonance spectroscopy. Ann Neurol 1995; 37: 204-210.
3. Seppi K, Schocke MF, Donnemiller E, et al. Comparison of diffusion-weighted imaging and [123I]IBZM-SPECT for the differentiation of patients with the Parkinson variant of multiple system atrophy from those with Parkinson’s disease. Mov Disord 2004; 19: 1438-1445.
4. Schulz JB, Skalej M, Wedekind D, et al. Magnetic resonance imaging-based volumetry differentiates idiopathic Parkinson’s syndrome from multiple system atrophy and progressive supranuclear palsy. Ann Neurol 1999; 45: 65-74.
5. Sener RN. Pelizaeus-Merzbacher disease: diffusion MR imaging and proton MR spectroscopy findings. J Neuroradiol 2004; 31: 138-141.
6. Harris JC, Lee RR, Jinnah HA, et al. Craniocerebral magnetic resonance imaging measurement and findings in Lesch-Nyhan syndrome. Arch Neurol 1998; 55: 547-553.
7. Baumeister FA, Auer DP, Hortnagel K, et al. The eye-of-the-tiger sign is not a reliable disease marker for Hallervorden-Spatz syndrome. Neuropediatrics 2005; 36: 221-222.
8. Brismar J, Ozand PT. CT and MR of the brain in glutaric acidemia type I: a review of 59 published cases and a report of 5 new patients. AJNR Am J Neuroradiol 1995; 16: 675-683.
9. Yesildag A, Ayata A, Baykal B, et al. Magnetic resonance imaging and diffusion-weighted imaging in methylmalonic acidemia. Acta Radiol 2005; 46: 101-103.
10. Faerber EN, Melvin J, Smergel EM. MRI appearances of metachromatic leukodystrophy. Pediatr Radiol 1999; 29: 669-672.
11. D’Incerti L. MRI in neuronal ceroid lipofuscinosis. Neurol Sci 2000; 21: S71-S73.
12. Caliskan M, Ozmen M, Beck M, et al. Thalamic hyperdensity-is it a diagnostic marker for Sandhoff disease? Brain Dev 1993; 15: 387-388.
13. Grosso S, Farnetani MA, Berardi R, et al. GM2 gangliosidosis variant B1 neuroradiological findings. J Neurol 2003; 250: 17-21.
14. Mugikura S, Takahashi S, Higano S, et al. MR findings in Tay-Sachs disease. J Comput Assist Tomogr 1996; 20: 551-555.
15. Bhatia KP, Marsden CD. The behavioural and motor consequences of focal lesions of the basal ganglia in man. Brain 1994; 117(Pt 4): 859-876.
16. Krystkowiak P, Martinat P, Defebvre L, et al. Dystonia after striatopallidal and thalamic stroke: clinicoradiological correlations and pathophysiological mechanisms. J Neurol Neurosurg Psychiatry 1998; 65: 703-708.
17. Lehericy S, Grand S, Pollak P, et al. Clinical characteristics and topography of lesions in movement disorders due to thalamic lesions. Neurology 2001; 57: 1055-1066.
18. Alarcon F, Zijlmans JC, Duenas G, et al. Post-stroke movement disorders: report of 56 patients. J Neurol Neurosurg Psychiatry 2004; 75: 1568-1574.
19. Ghika J, Ghika-Schmid F, Bogousslasvky J. Parietal motor syndrome: a clinical description in 32 patients in the acute phase of pure parietal strokes studied prospectively. Clin Neurol Neurosurg 1998; 100: 271-282.
20. Rondot P, Bathien N, Tempier P, et al. [Topography of secondary dystonia lesions]. Bull Acad Natl Med 2001; 185: 103-104.
21. Akbostanci MC, Yigit A, Ulkatan S. Cavernous angioma presenting with hemidystonia. Clin Neurol Neurosurg 1998; 100: 234-237.
22. Angelini L, Rumi V, Nardocci N, et al. Hemidystonia symptomatic of primary antiphospholipid syndrome in childhood. Mov Disord 1993; 8: 383-386.
23. Gille M, Van den BP, Ghariani S, et al. Delayed-onset hemidystonia and chorea following contralateral infarction of the posterolateral thalamus. A case report. Acta Neurol Belg 1996; 96: 307-311.
24. Leenders KL, Frackowiak RS, Quinn N, et al. Ipsilateral blepharospasm and contralateral hemidystonia and parkinsonism in a patient with a unilateral rostral brainstem-thalamic lesion: structural and functional abnormalities studied with CT, MRI, and PET scanning. Mov Disord 1986; 1: 51-58.
25. Matsuda M, Hashimoto T, Shimizu Y, et al. Coexistence of hemidystonia and hemiballism in a diabetic patient with striatal hyperintensity on T1-weighted MRI. J Neurol 2001; 248: 1096-1098.
26. Nardocci N, Zorzi G, Grisoli M, et al. Acquired hemidystonia in childhood: a clinical and neuroradiological study of thirteen patients. Pediatr Neurol 1996; 15: 108-113.
27. Lee MS, Rinne JO, Ceballos-Baumann A, et al. Dystonia after head trauma. Neurology 1994; 44: 1374-1378.
28. Krauss JK, Mohadjer M, Braus DF, et al. Dystonia following head trauma: a report of nine patients and review of the literature. Mov Disord 1992; 7: 263-272.
29. Warmuth-Metz M, Naumann M, Csoti I, et al. Measurement of the midbrain diameter on routine magnetic resonance imaging: a simple and accurate method of differentiating between Parkinson disease and progressive supranuclear palsy. Arch Neurol 2001; 58: 1076-1079.
30. Savoiardo M. Differential diagnosis of Parkinson’s disease and atypical parkinsonian disorders by magnetic resonance imaging. Neurol Sci 2003; 24(Suppl 1): S35-S37.
31. Watanabe H, Saito Y, Terao S, et al. Progression and prognosis in multiple system atrophy: an analysis of 230 Japanese patients. Brain 2002; 125: 1070-1083.
32. Louis ED, Lee P, Quinn L, et al. Dystonia in Huntington’s disease: prevalence and clinical characteristics. Mov Disord 1999; 14: 95-101.
33. Kassubek J, Juengling FD, Kioschies T, et al. Topography of cerebral atrophy in early Huntington’s disease: a voxel based morphometric MRI study. J Neurol Neurosurg Psychiatry 2004; 75: 213-220.
34. Starosta-Rubinstein S, Young AB, Kluin K, et al. Clinical assessment of 31 patients with Wilson’s disease. Correlations with structural changes on magnetic resonance imaging. Arch Neurol 1987; 44: 365-370.
35. Svetel M, Kozic D, Stefanova E, et al. Dystonia in Wilson’s disease. Mov Disord 2001; 16: 719-723.
36. Magalhaes AC, Caramelli P, Menezes JR, et al. Wilson’s disease: MRI with clinical correlation. Neuroradiology 1994; 36: 97-100.
37. Cordato DJ, Fulham MJ, Yiannikas C. Pretreatment and posttreatment positron emission tomographic scan imaging in a 20-year-old patient with Wilson’s disease. Mov Disord 1998; 13: 162-166.
38. Schlaug G, Hefter H, Engelbrecht V, et al. Neurological impairment and recovery in Wilson’s disease: evidence from PET and MRI. J Neurol Sci 1996; 136: 129-139.
39. Snow BJ, Bhatt M, Martin WR, et al. The nigrostriatal dopaminergic pathway in Wilson’s disease studied with positron emission tomography. J Neurol Neurosurg Psychiatry 1991; 54: 12-17.
40. Westermark K, Tedroff J, Thuomas KA, et al. Neurological Wilson’s disease studied with magnetic resonance imaging and with positron emission tomography using dopaminergic markers. Mov Disord 1995; 10: 596-603.
41. Schlaug G, Hefter H, Nebeling B, et al. Dopamine D2 receptor binding and cerebral glucose metabolism recover after D-penicillamine-therapy in Wilson’s disease. J Neurol 1994; 241: 577-584.
42. Schwarz J, Antonini A, Kraft E, et al. Treatment with D-penicillamine improves dopamine D2-receptor binding and T2-signal intensity in de novo Wilson’s disease. Neurology 1994; 44: 1079-1082.
43. Perlmutter JS, Tempel LW, Black KJ, et al. MPTP induces dystonia and parkinsonism. Clues to the pathophysiology of dystonia. Neurology 1997; 49: 1432-1438.
44. Furukawa Y, Hornykiewicz O, Fahn S, et al. Striatal dopamine in early-onset primary torsion dystonia with the DYT1 mutation. Neurology 2000; 54: 1193-1195.
45. Hornykiewicz O, Kish SJ, Becker LE, et al. Brain neurotransmitters in dystonia musculorum deformans. N Engl J Med 1986; 315: 347-353.
46. Augood SJ, Hollingsworth Z, Albers DS, et al. Dopamine transmission in DYT1 dystonia: a biochemical and autoradiographical study. Neurology 2002; 59: 445-448.
47. Otsuka M, Ichiya Y, Shima F, et al. Increased striatal 18F-dopa uptake and normal glucose metabolism in idiopathic dystonia syndrome. J Neurol Sci 1992; 111: 195-199.
48. Playford ED, Fletcher NA, Sawle GV, et al. Striatal [18F]dopa uptake in familial idiopathic dystonia. Brain 1993; 116(Pt 5): 1191-1199.
49. Leenders KL, Quinn N, Frackowiak RS, et al. Brain dopaminergic system studied in patients with dystonia using positron emission tomography. Adv Neurol 1988; 50: 243-247.
50. Naumann M, Pirker W, Reiners K, et al. Imaging the pre- and postsynaptic side of striatal dopaminergic synapses in idiopathic cervical dystonia: a SPECT study using [123I] epidepride and [123I] beta-CIT. Mov Disord 1998; 13: 319-323.
51. Torres GE, Sweeney AL, Beaulieu JM, et al. Effect of torsinA on membrane proteins reveals a loss of function and a dominant-negative phenotype of the dystonia-associated DeltaE-torsinA mutant. Proc Natl Acad Sci U S A 2004; 101: 15650-15655.
52. Ichinose H, Ohye T, Takahashi E, et al. Hereditary progressive dystonia with marked diurnal fluctuation caused by mutations in the GTP cyclohydrolase I gene. Nat Genet 1994; 8: 236-242.
53. Sawle GV, Leenders KL, Brooks DJ, et al. Dopa-responsive dystonia: [18F]dopa positron emission tomography. Ann Neurol 1991; 30: 24-30.
54. Turjanski N, Bhatia K, Burn DJ, et al. Comparison of striatal 18F-dopa uptake in adult-onset dystonia-parkinsonism, Parkinson’s disease, and dopa-responsive dystonia. Neurology 1993; 43: 1563-1568.
55. Snow BJ, Nygaard TG, Takahashi H, et al. Positron emission tomographic studies of dopa-responsive dystonia and early-onset idiopathic parkinsonism. Ann Neurol 1993; 34: 733-738.
56. Fuente-Fernandez R, Furtado S, Guttman M, et al. VMAT2 binding is elevated in doparesponsive dystonia: visualizing empty vesicles by PET. Synapse 2003; 49: 20-28.
57. Rinne JO, Iivanainen M, Metsahonkala L, et al. Striatal dopaminergic system in doparesponsive dystonia: a multi-tracer PET study shows increased D2 receptors. J Neural Transm 2004; 111: 59-67.
58. Jeon BS, Jeong JM, Park SS, et al. Dopamine transporter density measured by [123I] beta-CIT single-photon emission computed tomography is normal in dopa-responsive dystonia. Ann Neurol 1998; 43: 792-800.
59. Naumann M, Pirker W, Reiners K, et al. [123I]beta-CIT single-photon emission tomography in DOPA-responsive dystonia. Mov Disord 1997; 12: 448-451.
60. O’Sullivan JD, Costa DC, Gacinovic S, et al. SPECT imaging of the dopamine transporter in juvenile-onset dystonia. Neurology 2001; 56: 266-267.
61. Kishore A, Nygaard TG, Fuente-Fernandez R, et al. Striatal D2 receptors in symptomatic and asymptomatic carriers of dopa-responsive dystonia measured with [11C]-raclopride and positron-emission tomography. Neurology 1998; 50: 1028-1032.
62. Kunig G, Leenders KL, Antonini A, et al. D2 receptor binding in dopa-responsive dystonia. Ann Neurol 1998; 44: 758-762.
63. Carbon M, Trost M, Ghilardi MF, et al. Abnormal brain networks in primary torsion dystonia. Adv Neurol 2004; 94: 155-161.
64. Eidelberg D, Moeller JR, Ishikawa T, et al. The metabolic topography of idiopathic torsion dystonia. Brain 1995; 118(Pt 6): 1473-1484.
65. Ibanez V, Sadato N, Karp B, et al. Deficient activation of the motor cortical network in patients with writer’s cramp. Neurology 1999; 53: 96-105.
66. Stoessl AJ, Martin WR, Clark C, et al. PET studies of cerebral glucose metabolism in idiopathic torticollis. Neurology 1986; 36: 653-657.
67. Pujol J, Roset-Llobet J, Rosines-Cubells D, et al. Brain cortical activation during guitarinduced hand dystonia studied by functional MRI. Neuroimage 2000; 12: 257-267.
68. Ceballos-Baumann AO, Passingham RE, Warner T, et al. Overactive prefrontal and underactive motor cortical areas in idiopathic dystonia. Ann Neurol 1995; 37: 363-372.
69. Galardi G, Perani D, Grassi F, et al. Basal ganglia and thalamo-cortical hypermetabolism in patients with spasmodic torticollis. Acta Neurol Scand 1996; 94: 172-176.
70. Furukawa Y, Nygaard TG, Gutlich M, et al. Striatal biopterin and tyrosine hydroxylase protein reduction in dopa-responsive dystonia. Neurology 1999; 53: 1032-1041.
71. Fuente-Fernandez R, Schulzer M, Mak E, et al. Presynaptic mechanisms of motor fluctuations in Parkinson’s disease: a probabilistic model. Brain 2004; 127: 888-899.
72. Augood SJ, Penney JB Jr, Friberg IK, et al. Expression of the early-onset torsion dystonia gene (DYT1) in human brain. Ann Neurol 1998; 43: 669-673.
73. McNaught KS, Kapustin A, Jackson T, et al. Brainstem pathology in DYT1 primary torsion dystonia. Ann Neurol 2004; 56: 540-547.
74. Edwards MJ, Huang YZ, Wood NW, et al. Different patterns of electrophysiological deficits in manifesting and non-manifesting carriers of the DYT1 gene mutation. Brain 2003; 126: 2074-2080.
75. Sharma N, Baxter MG, Petravicz J, et al. Impaired motor learning in mice expressing torsinA with the DYT1 dystonia mutation. J Neurosci 2005; 25: 5351-5355.
76. Ghilardi MF, Carbon M, Silvestri G, et al. Impaired sequence learning in carriers of the DYT1 dystonia mutation. Ann Neurol 2003; 54: 102-109.
77. Oppenheim C, Rodrigo S, Poupon C, et al. [Diffusion tensor MR imaging of the brain. Clinical applications.]. J Radiol 2004; 85: 287-296.
78. Ramnani N, Behrens TE, Penny W, et al. New approaches for exploring anatomical and functional connectivity in the human brain. Biol Psychiatry 2004; 56: 613-619.
79. Le Bihan D. Looking into the functional architecture of the brain with diffusion MRI. Nat Rev Neurosci 2003; 4: 469-480.
80. Carbon M, Kingsley PB, Su S, et al. Microstructural white matter changes in carriers of the DYT1 gene mutation. Ann Neurol 2004; 56: 283-286.
81. Black KJ, Gado MH, Perlmutter JS. PET measurement of dopamine D2 receptormediated changes in striatopallidal function. J Neurosci 1997; 17: 3168-3177.
82. Asanuma K, Ma Y, Okulski J, et al. Decreased striatal D2 receptor binding in nonmanifesting carriers of the DYT1 dystonia mutation. Neurology 2005; 64: 347-349.
83. Perlmutter JS, Stambuk MK, Markham J, et al. Decreased [18F]spiperone binding in putamen in idiopathic focal dystonia. J Neurosci 1997; 17: 843-850.
84. Nobrega JN, Richter A, Tozman N, et al. Quantitative autoradiography reveals regionally selective changes in dopamine D1 and D2 receptor binding in the genetically dystonic hamster. Neuroscience 1996; 71: 927-937.
85. Eidelberg D, Moeller JR, Dhawan V, et al. The metabolic topography of parkinsonism. J Cereb Blood Flow Metab 1994; 14: 783-801.
86. Trost M, Carbon M, Edwards C, et al. Primary dystonia: is abnormal functional brain architecture linked to genotype?. Ann Neurol 2002; 52: 853-856.
87. Lozano AM, Abosch A. Pallidal stimulation for dystonia. Adv Neurol 2004; 94: 301-308.
88. Detante O, Vercueil L, Thobois S, et al. Globus pallidus internus stimulation in primary generalized dystonia: a H215O PET study. Brain 2004; 127: 1899-1908.
89. Eidelberg D, Moeller JR, Antonini A, et al. Functional brain networks in DYT1 dystonia. Ann Neurol 1998; 44: 303-312.
90. Kaji R, Rothwell JC, Katayama M, et al. Tonic vibration reflex and muscle afferent block in writer’s cramp. Ann Neurol 1995; 38: 155-162.
91. Playford ED, Passingham RE, Marsden CD, et al. Increased activation of frontal areas during arm movement in idiopathic torsion dystonia. Mov Disord 1998; 13: 309-318.
92. Oga T, Honda M, Toma K, et al. Abnormal cortical mechanisms of voluntary muscle relaxation in patients with writer’s cramp: an fMRI study. Brain 2002; 125: 895-903.
93. Delmaire C, Krainik A, Tezenas du MS, et al. Disorganized somatotopy in the putamen of patients with focal hand dystonia. Neurology 2005; 64: 1391-1396.
94. Odergren T, Stone-Elander S, Ingvar M. Cerebral and cerebellar activation in correlation to the action-induced dystonia in writer’s cramp. Mov Disord 1998; 13: 497-508.
95. Karbe H, Holthoff VA, Rudolf J, et al. Positron emission tomography demonstrates frontal cortex and basal ganglia hypometabolism in dystonia. Neurology 1992; 42: 1540-1544.